Delivery Order SPE2DB24D1205-SPE2DB25FCSXN

Award Date 1/8/25
Potential Completion Date 1/9/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of QULIPTA 30 MG TABLET 30S to the Defense Logistics Agency (DLA). The $1,116.21 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 5, 2024, with a completion date of April 26, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award is for the delivery of QULIPTA 60 MG TABLET 30S to the Defense Logistics Agency (DLA). The $14,915.90 firm fixed-price delivery order was awarded on October 31, 2024 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a completion date of November 1, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $1,116.21 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of QULIPTA 30 MG TABLET 30S, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $3,127.92 firm-fixed-price delivery order is for the supply of QULIPTA 60 MG TABLET 30S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,863.87 Firm Fixed Price delivery order contract is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of QULIPTA 60 MG TABLET 30S. The contract, valued at $11,031.34, is a Firm Fixed Price Delivery Order that runs through September 26, 2024. The award is not associated with a set-aside program. Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and the Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of QULIPTA 60 MG TABLET 30S. The $2,484.00 firm fixed-price delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies,...
This federal contract award, valued at $3,653.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of October 31, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, with an ID of SPE2DX15D3005|SPE2DX24F3TZX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of 4565618180 ! QULIPTA 60 MG TABLET 30S. The contract has a firm fixed-price, delivery order pricing type, and a ceiling value of $4,878.61. The ultimate completion date is August 29, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant...
This federal contract award is a delivery order worth $2,704.41 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of QULIPTA 60 MG TABLET 30S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a vehicle for providing a comprehensive range of...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCSXN
    Delivery Order

This federal contract award is for the delivery of QULIPTA 60 MG TABLET 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,736.83 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/9/25, 9:57 AM